21 May 2013
Keywords: strong, ph, iii, data, revolade, chronic, itp
Article | 18 June 2007
UK drug major GlaxoSmithKline says that, in an international, pivotal Phase III study, its investigational non-peptide oral platelet growth
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 June 2007
20 May 2013
© 2013 thepharmaletter.com